| Patrick Hinton, DPT | |
|
315 E 3rd St, Corinth, MS 38834-3406 | |
| (662) 415-2782 | |
| Not Available |
| Full Name | Patrick Hinton |
|---|---|
| Gender | Male |
| Speciality | Physical Therapy |
| Experience | 10 Years |
| Location | 315 E 3rd St, Corinth, Mississippi |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1285080689 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | 5534 (Mississippi) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Anchor Rehabilitation Llc | 2961774047 | 4 |
News Archive
The most difficult challenge in finding substance abuse treatment for a loved one is how to know which programs have a proven track record. That is just one of the topics being discussed today at the conference "Blending Addiction Science and Treatment: The Impact of Evidence-Based Practices on Individuals, Families and Communities." Held at the Duke Energy Center in Cincinnati, the conference is hosted by the National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health. It is part of NIDA's Blending Initiative, in which teams of experts create clinical tools based on the latest treatment research.
Researchers from the Cardiovascular Institute at Rhode Island, The Miriam and Newport hospitals will present 22 abstracts, both poster and oral presentations, at the upcoming American Heart Association Scientific Sessions, to be held in Dallas November 16-20, 2013. Scientific Sessions is the foremost cardiovascular research meeting in the U.S., with more than 18,000 cardiovascular experts from more than 105 countries in attendance.
New research from the Trudeau Institute addresses how the human body controls gamma-herpesviruses, a class of viruses thought to cause a variety of cancers. The study, carried out in the laboratory of Dr. Marcia Blackman, awaits publication in The Journal of Immunology.
Researchers from Fox Chase Cancer Center and other institutions have completed a phase II clinical trial that may help identify those patients with HPV-positive oropharyngeal cancer who do not require the full radiation dose given in a standard regimen of Intensity-Modulated Radiation Therapy (IMRT). Preliminary findings will be presented by Shanthi Marur, first author on the study and an oncologist at the Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, at the 49th Annual Meeting of the American Society of Clinical Oncology on Sunday, June 2.
› Verified 3 days ago
| Provider Name | Anchor Rehabilitation Llc |
|---|---|
| Provider Type | Part B Supplier - Physical/occupational Therapy Group In Private Practice |
| Provider Identifiers | NPI Number: 1922542646 PECOS PAC ID: 2961774047 Enrollment ID: O20170824001399 |
News Archive
The most difficult challenge in finding substance abuse treatment for a loved one is how to know which programs have a proven track record. That is just one of the topics being discussed today at the conference "Blending Addiction Science and Treatment: The Impact of Evidence-Based Practices on Individuals, Families and Communities." Held at the Duke Energy Center in Cincinnati, the conference is hosted by the National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health. It is part of NIDA's Blending Initiative, in which teams of experts create clinical tools based on the latest treatment research.
Researchers from the Cardiovascular Institute at Rhode Island, The Miriam and Newport hospitals will present 22 abstracts, both poster and oral presentations, at the upcoming American Heart Association Scientific Sessions, to be held in Dallas November 16-20, 2013. Scientific Sessions is the foremost cardiovascular research meeting in the U.S., with more than 18,000 cardiovascular experts from more than 105 countries in attendance.
New research from the Trudeau Institute addresses how the human body controls gamma-herpesviruses, a class of viruses thought to cause a variety of cancers. The study, carried out in the laboratory of Dr. Marcia Blackman, awaits publication in The Journal of Immunology.
Researchers from Fox Chase Cancer Center and other institutions have completed a phase II clinical trial that may help identify those patients with HPV-positive oropharyngeal cancer who do not require the full radiation dose given in a standard regimen of Intensity-Modulated Radiation Therapy (IMRT). Preliminary findings will be presented by Shanthi Marur, first author on the study and an oncologist at the Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, at the 49th Annual Meeting of the American Society of Clinical Oncology on Sunday, June 2.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Patrick Hinton, DPT 315 E 3rd St, Corinth, MS 38834-3406 Ph: (662) 415-2782 | Patrick Hinton, DPT 315 E 3rd St, Corinth, MS 38834-3406 Ph: (662) 415-2782 |
News Archive
The most difficult challenge in finding substance abuse treatment for a loved one is how to know which programs have a proven track record. That is just one of the topics being discussed today at the conference "Blending Addiction Science and Treatment: The Impact of Evidence-Based Practices on Individuals, Families and Communities." Held at the Duke Energy Center in Cincinnati, the conference is hosted by the National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health. It is part of NIDA's Blending Initiative, in which teams of experts create clinical tools based on the latest treatment research.
Researchers from the Cardiovascular Institute at Rhode Island, The Miriam and Newport hospitals will present 22 abstracts, both poster and oral presentations, at the upcoming American Heart Association Scientific Sessions, to be held in Dallas November 16-20, 2013. Scientific Sessions is the foremost cardiovascular research meeting in the U.S., with more than 18,000 cardiovascular experts from more than 105 countries in attendance.
New research from the Trudeau Institute addresses how the human body controls gamma-herpesviruses, a class of viruses thought to cause a variety of cancers. The study, carried out in the laboratory of Dr. Marcia Blackman, awaits publication in The Journal of Immunology.
Researchers from Fox Chase Cancer Center and other institutions have completed a phase II clinical trial that may help identify those patients with HPV-positive oropharyngeal cancer who do not require the full radiation dose given in a standard regimen of Intensity-Modulated Radiation Therapy (IMRT). Preliminary findings will be presented by Shanthi Marur, first author on the study and an oncologist at the Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, at the 49th Annual Meeting of the American Society of Clinical Oncology on Sunday, June 2.
› Verified 3 days ago
Mrs. Ashleigh Wilson Dalton, P.T. Physical Therapist Medicare: Medicare Enrolled Practice Location: 2008 Willow Rd, Corinth, MS 38834 Phone: 423-747-6047 | |
Mr. William Mark Rhodes, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 2106 S Tate St Ste E, Corinth, MS 38834 Phone: 662-643-4043 Fax: 662-643-4044 | |
Robin Dawn Arnwine, P.T. Physical Therapist Medicare: Medicare Enrolled Practice Location: 703 Alcorn Dr, Suite 109, Corinth, MS 38834 Phone: 662-286-6369 Fax: 662-286-2768 | |
Ch&r Of Corinth, Llc Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 302 Alcorn Dr, Corinth, MS 38834 Phone: 662-226-2286 Fax: 662-226-2289 | |
Meredith W Hood, DPT Physical Therapist Medicare: Medicare Enrolled Practice Location: 2503 Virginia Ln, Corinth, MS 38834 Phone: 662-977-7180 Fax: 662-977-7182 | |
Kyle G Graham, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 2503 Virginia Ln, Corinth, MS 38834 Phone: 662-977-7180 Fax: 662-997-7182 |